We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$6.19B
AUM Growth
+$180M
Cap. Flow
-$115M
Cap. Flow %
-1.85%
Top 10 Hldgs %
21.67%
Holding
241
New
11
Increased
68
Reduced
137
Closed
2

Top Buys

Rank Stock Value
1
RXO icon
RXO
RXO
+$16.9M
2
CLF icon
Cleveland-Cliffs
CLF
+$11.1M
3
CVS icon
CVS Health
CVS
+$8.97M
4
AA icon
Alcoa
AA
+$8.4M
5
IFF icon
International Flavors & Fragrances
IFF
+$7.96M

Sector Composition

Rank Sector Weight
1 Financials 17.68%
2 Technology 16.56%
3 Healthcare 15.52%
4 Industrials 11.68%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.72T
$187M 3.03%
4,431,550
-447,120
-9% -$14.8M
MSFT icon
2
Microsoft
MSFT
$3.35T
$173M 2.8%
508,576
-19,522
-4% -$6.12M
QCOM icon
3
Qualcomm
QCOM
$160B
$158M 2.56%
1,331,000
+1,938
+0.1% +$223K
JPM icon
4
JPMorgan Chase
JPM
$933B
$134M 2.17%
923,311
-12,954
-1% -$1.78M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.08T
$128M 2.06%
1,054,880
-12,695
-1% -$1.47M
DAL icon
6
Delta Air Lines
DAL
$58.3B
$119M 1.93%
2,511,867
-3,158
-0.1% -$116K
AXP icon
7
American Express
AXP
$228B
$115M 1.87%
663,026
-14,447
-2% -$2.33M
V icon
8
Visa
V
$673B
$110M 1.78%
465,257
-21,540
-4% -$4.93M
BMY icon
9
Bristol-Myers Squibb
BMY
$132B
$109M 1.76%
1,706,637
-12,712
-0.7% -$852K
GE icon
10
GE Aerospace
GE
$368B
$106M 1.71%
1,211,264
-43,505
-3% -$3.52M
GM icon
11
General Motors
GM
$80B
$104M 1.68%
2,695,906
-25,253
-0.9% -$873K
MA icon
12
Mastercard
MA
$510B
$100M 1.62%
254,819
-9,400
-4% -$3.53M
TMO icon
13
Thermo Fisher Scientific
TMO
$214B
$97.3M 1.57%
186,575
-8,584
-4% -$4.63M
RGA icon
14
Reinsurance Group of America
RGA
$15.6B
$93.7M 1.51%
675,825
-14,564
-2% -$2.07M
CMCSA icon
15
Comcast
CMCSA
$84B
$91.6M 1.48%
2,205,060
+40,834
+2% +$1.62M
ZBH icon
16
Zimmer Biomet
ZBH
$18.4B
$91.2M 1.47%
626,044
-15,685
-2% -$2.13M
CHTR icon
17
Charter Communications
CHTR
$16.9B
$90M 1.45%
245,064
+20,094
+9% +$6.86M
MS icon
18
Morgan Stanley
MS
$330B
$89.9M 1.45%
1,053,100
-8,631
-0.8% -$738K
BX icon
19
Blackstone
BX
$102B
$87.5M 1.41%
941,612
-30,051
-3% -$2.6M
DEO icon
20
Diageo
DEO
$49.5B
$86.4M 1.4%
498,041
-3,343
-0.7% -$597K
ORCL icon
21
Oracle
ORCL
$367B
$83.8M 1.35%
704,036
-144,819
-17% -$15M
TDG icon
22
TransDigm Group
TDG
$69.9B
$82.4M 1.33%
92,119
-827
-0.9% -$654K
PRU icon
23
Prudential Financial
PRU
$42.6B
$81.4M 1.32%
923,007
-43,250
-4% -$3.62M
EQIX icon
24
Equinix
EQIX
$103B
$80.3M 1.3%
102,448
-2,635
-3% -$1.93M
DHR icon
25
Danaher
DHR
$138B
$79.8M 1.29%
375,245
-6,643
-2% -$1.41M

Similar funds

Douglas Lane & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Douglas Lane & Associates held 241 positions worth $6.19B, up 3% from $6.01B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q2 2023 filing shows 11 new, 68 increased, 137 reduced and 2 closed positions. Its largest new stake was Wheaton Precious Metals: 108,375 shares worth $4.68M. The largest sale was Maxar Technologies Inc. Common Stock, an estimated $82.8M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q2 2023 buy was Wheaton Precious Metals: 108,375 shares worth $4.68M.
  • Douglas Lane & Associates added most to RXO in Q2 2023, an estimated $16.9M increase.
  • Douglas Lane & Associates's biggest Q2 2023 reduction was Electronic Arts, cutting an estimated $23.5M.
  • Douglas Lane & Associates fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $82.8M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $6.19B portfolio in Q2 2023.
  • Douglas Lane & Associates opened 11 new positions and closed 2 in Q2 2023.
  • Douglas Lane & Associates's portfolio value rose 3% quarter-over-quarter to $6.19B.

Based on Douglas Lane & Associates's 13F filing for Q2 2023, filed 19 Jul 2023.